About Enable Injections
Enable Injections is a private company based in Cincinnati, Ohio. It has reported $244,985,595 raised in 11 offerings on Form D since August 2016.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 29, 2025 | Jan 9, 2026 | $29,999,997fully sold | 1 | $29.9M | EquityRule 506(b) | Form D ↗ |
| Jan 27, 2022 | Feb 3, 2022 | $150,044,600of $215.0M target | 22 | $6.8M | Equity, DebtRule 506(b) | Form D ↗ |
| Oct 22, 2018 | Oct 30, 2018 | $30,670,823of $50.0M target | 15 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Aug 26, 2016 | Sep 1, 2016amended Nov 17, 2016 | $25,000,000fully sold | 1 | $25.0M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 1, 2014 | Aug 24, 2016 | $22,925fully sold | 1 | $22,925 | EquityRule 504 | Form D ↗ |
| May 5, 2012 | Aug 22, 2016 | $2,000,000fully sold | 13 | $153K | EquityRule 506(b) | Form D ↗ |
| May 1, 2015 | Aug 11, 2016amended Aug 17, 2016 | $247,250fully sold | 0 | — | Debt, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Not yet | Aug 11, 2016amended Aug 17, 2016 | $0of $9,617 target | 0 | — | Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Not yet | Aug 11, 2016amended Aug 17, 2016 | $0of $100K target | 0 | — | Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 1, 2016 | Aug 2, 2016amended Aug 17, 2016 | $5,000,000fully sold | 19 | $263K | Debt, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Sep 5, 2014 | Sep 18, 2014amended Apr 18, 2016 | $2,000,000of $5.0M target | 13 | $153K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, 11 offerings | $244,985,595 | |||||
The filing for the offering first filed Aug 11, 2016 reports amount sold with no investors. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Enable Injections's Form D filed Jan 9, 2026.
Earlier filings also listed Norman Weldon (director, last listed Feb 2022), Karen Robards (director, last listed Feb 2022), Susan Spies (executive officer, last listed Oct 2018), Mark Collar (director, last listed Oct 2018) and Daniel von Allmen (director, last listed Oct 2018).
Sources
- SECENABLE INJECTIONS, INC Form D, filed Sep 1, 2016
- SECENABLE INJECTIONS, INC Form D, filed Aug 11, 2016
- SECENABLE INJECTIONS, INC Form D, filed Aug 11, 2016
- SECENABLE INJECTIONS, INC Form D, filed Aug 11, 2016
- SECENABLE INJECTIONS, INC Form D, filed Aug 2, 2016
- SECENABLE INJECTIONS, INC Form D, filed Sep 18, 2014
- SECENABLE INJECTIONS, INC filing history